USAID Grants $10M To DNDi For NTD Drug R&D
Drugs for Neglected Diseases initiative: DNDi Receives US$ 10 Million from USAID to Develop New Drugs for Neglected Filaria Patients
“The Drugs for Neglected Diseases initiative (DNDi) has been awarded US$ 10 million by the United States Agency for International Development (USAID) to develop new treatments for onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis) — the first-ever USAID grant for neglected tropical disease research and development (R&D)…” (12/16).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.